Blog - Vital Signs - Life Science Business Development & Finance

Pfizer Beats Out Sanofi to Take Medivation for $14 Billion

The Odd Juxtaposition In Biotech Venture Capital: Delivering Returns Amidst Sliding Market Share

This big biotech boosts its deep Bay Area cancer-fighting portfolio

Setting the Body’s ‘SerialKillers’ Loose on Cancer

Tesaro’s PARP ovarian cancer drug hits PhIII goal; prepares to file

This Is the Most Important Business Trend in Pharma

Biotech Labs Birth New Drugs—and New Fortunes

Facebook, Napster billionaire Parker to fund first-ever CRISPR trial

US bid to grow human organs for transplant inside pigs

Scientists Talk Privately About Creating a Synthetic Human Genome